Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Third Edition BOGP (10)
Allemagne (2)
Policy
Neurology/Parkinson's Disease (1)
Start Up (3)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Capacity and capabilities for engagement
Clinical study phase I